Saint-Max, France

Jean Duheille

This inventor holds 1 USPTO granted patent. Top assignee: Sanofi. Active years: 1987.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jean Duheille: Innovator in Microparticle Technology

Introduction

Jean Duheille is a notable inventor based in Saint-Max, France. He has made significant contributions to the field of microparticle technology, particularly in the area of biomedical applications. His innovative work has led to the development of a unique method for the nephelometric determination of HB.sub.s antigen.

Latest Patents

Duheille holds a patent for the "Nephelometric determination of HB.sub.s antigen with antibody-containing microparticles." This invention involves polyfunctional hydrophilic spherical microparticles of uniform size, which contain a specific composition of copolymerized units. The microparticles are designed for the precise determination of HB.sub.s antigen, showcasing Duheille's expertise in the field.

Career Highlights

Throughout his career, Duheille has been associated with Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to focus on innovative solutions in the biomedical sector. With a patent portfolio that includes 1 patent, Duheille has established himself as a key figure in his area of expertise.

Collaborations

Duheille has collaborated with notable colleagues such as Bernard Pau and Pierre Gros. These partnerships have contributed to the advancement of research and development in microparticle technology.

Conclusion

Jean Duheille's contributions to the field of microparticle technology and his innovative patent demonstrate his commitment to advancing biomedical applications. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…